Giacobello Scott M.

CHIEF FINANCIAL OFFICERWhitehawk Therapeutics, Inc. (WHWK) · full profile →Form 4 · filed Apr 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$882K
Net Open-Market Flow
-$882K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 16, 2026Sell(S)142K$4.13$585K295K
Apr 15, 2026Sell(S)77K$3.86$297K437K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001754154-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly: